Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

UNITED FIRE GROUP INC (UFCS)

  • Business News
  • May 05, 2026, 20:01 UTC
  • 1
  • 1 comments

United Fire Group, Inc. reports first quarter 2026 results

Market reaction Comment Full text

ULTRAGENYX PHARMACEUTICAL INC. (RARE)

  • Business News
  • May 05, 2026, 20:01 UTC
  • 1
  • 1 comments

Ultragenyx Reports First Quarter 2026 Financial Results and Corporate Update

Market reaction Comment Full text

TEMPUS AI, INC. (TEM)

  • Business News
  • May 05, 2026, 20:01 UTC
  • 1
  • 1 comments

Tempus Reports First Quarter 2026 Results

Market reaction Comment Full text

DIANTHUS THERAPEUTICS, INC. /DE/ (DNTH)

  • Business News
  • May 05, 2026, 20:01 UTC
  • 0
  • 1 comments

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 2026 Financial Results

Market reaction Comment Full text

INMUNE BIO, INC. (INMB)

  • Business News
  • May 05, 2026, 20:00 UTC
  • 1
  • 1 comments

INmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases

Market reaction Comment Full text

SES AI CORP (SES)

  • Business News
  • May 05, 2026, 20:00 UTC
  • 0
  • 1 comments

SES Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in SES AI Corporation Securities Lawsuit - Contact Levi & Korsinsky

Market reaction Comment Full text

QORVO, INC. (QRVO)

  • Business News
  • May 05, 2026, 20:00 UTC
  • 1
  • 1 comments

Qorvo® Announces Fiscal 2026 Fourth Quarter Financial Results

Market reaction Comment Full text

ACUMEN PHARMACEUTICALS, INC. (ABOS)

  • Business News
  • May 05, 2026, 20:00 UTC
  • 0
  • 1 comments

Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026

Market reaction Comment Full text

GLOBANT S.A. (GLOB)

  • Business News
  • May 05, 2026, 20:00 UTC
  • 0
  • 1 comments

GLOB Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Globant S.A. Securities Lawsuit - Contact Levi & Korsinsky

Market reaction Comment Full text

IMMUNOME INC. (IMNM)

  • Business News
  • May 05, 2026, 20:00 UTC
  • 1
  • 1 comments

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text
  • Previous
  • 274
  • 275
  • 276
  • 277
  • 278
  • Next

Search

News categories

  • Technical Exchange News(12370)
  • Event(6229)
  • SEC News(271857)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158076)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin